Back to search

Svp Pharma Ltd

13849821

active
ltd
england wales
Companies House
Health Score
70 / 100

Some Concerns

30/30
Filing
0/30
Financial
40/40
Risk
  • Negative net worth (-10)
  • Current liabilities exceed current assets (-10)

Details

Unit 1 39 Mahoney Green, Rackheath, Norwich, NR13 6JY
Incorporated 14/01/2022

Compliance

Last accounts

31/12/2025

total exemption full

Next accounts due

30/09/2027

On track

Confirmation statement

Last: 14/01/2026

Due 28/01/2027

On track

Industry

21100
Manufacture of basic pharmaceutical products

Officers

Joaquim Antonio De Matos Chaves

director · Since 14/01/2022

Portuguese · Portugal · Age 58

LuíS Pedro GonçAlves SimõEs

director · Since 14/01/2022

Portuguese · Portugal · Age 54

Chandrakant Vallabhdas Ondhia

director · Since 14/01/2022

British · United Kingdom · Age 72

Andrew Keith Waide

director · Since 14/01/2022

British · United Kingdom · Age 67

Persons with Significant Control

Yang Sing Pharma Ltd

25–50% shares
25–50% votes

85, Yarmouth Road, Norwich, NR13 4LQ

Reg: 13078051 · Companies House · Limited

Notified 14/01/2022

Joaquim Antonio De Matos Chaves

ownership-of-shares-25-to-50-percent-as-firm
voting-rights-25-to-50-percent-as-firm

Portuguese · Portugal · Age 58

Parque Industrial Manuel Lourenço Ferreira, Lote 2, Mortágua

Notified 14/01/2022

Luís Pedro Gonçalves Simões

ownership-of-shares-25-to-50-percent-as-firm
voting-rights-25-to-50-percent-as-firm

Portuguese · Portugal · Age 54

Parque Industrial Manuel Lourenço Ferreira, Lote 2, Mortágua

Notified 14/01/2022

Change History

officer appointed → WAIDE, Andrew Keith
2026-06-07
officer appointed → DE MATOS CHAVES, Joaquim Antonio
2026-06-07
officer appointed → GONÇALVES SIMÕES, Luís Pedro
2026-06-07
officer appointed → ONDHIA, Chandrakant Vallabhdas
2026-06-07
status → active
2026-06-07

Active

type → ltd
2026-06-07

Private Limited Company

address line1 → Unit 1 39 Mahoney Green
2026-06-07

UNIT 1 39 MAHONEY GREEN

post town → Norwich
2026-06-07

NORWICH

CompanyRankvs 852+ SIC 21100 peers
30

Financial strength3th percentile among SIC peers · 1/25
Employees27th percentile among SIC peers · 4/15
LiquidityCurrent ratio 0.93× · 6/20
Longevity4 years trading (max 15) · 4/15
Filing complianceAll filings up to date · 15/15
Show leaderboard
1Lofthouse Of Fleetwood Limited
90
2West Pharmaceutical Services Cornwall Limited
90
3Dr. Reddy'S Laboratories (Eu) Limited
90
4Mw Encap Limited
90
5Rsr Limited
90
6Aura-Soma Products Limited
89
7Tcs Biosciences Limited
89
8Pharmapac (U.K.) Limited
89
9Onyx Scientific Limited
89
10International Scientific Supplies Limited
89
852Svp Pharma Ltd
26
How is this score calculated?
Financial strength1/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees4/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity6/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity4/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Key FinancialsYear ending 31/12/2025

Net Worth

-£434k

Balance sheet strength

Cash

£43k

Cash in the bank

Net Current Assets

-£36k

Working capital

Current Assets

£459k

Current Liabilities

£495k

Debtors

£154k

0avg. employees
Prepared with CCH Software

EstimatesDerived

YearCurrent RatioImplied Profit
20250.93+£0
20250.93-£181k
202434.27-£24k
20230.40-£113k

Derived from filed accounts. Not audited figures.